.Bicara Rehabs and also Zenas Biopharma have supplied fresh catalyst to the IPO market with filings ...
.Genentech is going to close its own cancer immunology research department, and device mind and also...
.Kezar Life Sciences is actually dropping its own dim phase 1 sound lump drug as the biotech goes al...
.Regardless of izokibep keeping its newly found winning touch in the center, Acelyrin is actually no...
.Rivus Pharmaceuticals has plumped up the leads of its fat-busting, muscle-sparing drug applicant, r...
.Ovid Rehab actually disclosed last month that it was actually trimming its headcount as the company...
.Eli Lilly has actually opened up a $700 thousand R&D facility in the Boston Port, enhancing its ...
.Just five months after protecting a $100 thousand IPO, Vast Bio is currently giving up some staff m...
.The first phases of oncology R&D aren't except appealing new modalities, as well as Halda Therap...
.Psychopharmacology has pulled 3 write-ups regarding midstage professional test data assessing Lykos...